Next Article in Journal
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications
Next Article in Special Issue
Exploring Wound-Healing Genomic Machinery with a Network-Based Approach
Previous Article in Journal
Anti-Mycobacterial Evaluation of 7-Chloro-4-Aminoquinolines and Hologram Quantitative Structure–Activity Relationship (HQSAR) Modeling of Amino–Imino Tautomers
Previous Article in Special Issue
PKC in Regenerative Therapy: New Insights for Old Targets
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle
Pharmaceuticals 2017, 10(2), 53; doi:10.3390/ph10020053

In Vitro and In Vivo Studies of Alar-Nasal Cartilage Using Autologous Micro-Grafts: The Use of the Rigenera® Protocol in the Treatment of an Osteochondral Lesion of the Nose

1
Department of Public Health, Experimental Medicine and Forensic, Human Anatomy Unit, University of Pavia, Pavia 27100, Italy
2
Center for Health Technologies, University of Pavia, Pavia 27100, Italy
3
Chief of Plastic and Reconstructive Surgery, Catholic University, Tirana 1005, Albania
4
Plastic and Reconstructive Surgery Department, University of Rome “Tor Vergata”, Rome 00173, Italy
5
Santa Croce Hospital, Unit of Orthopedics and Traumatology of Chieri and Moncalieri, Turin 10024, Italy
*
Authors to whom correspondence should be addressed.
Academic Editors: Jean Jacques Vanden Eynde and Simona Collina
Received: 28 April 2017 / Revised: 7 June 2017 / Accepted: 9 June 2017 / Published: 13 June 2017
(This article belongs to the Special Issue Tissue-Protective Agents: New Drugs and Technologies)
View Full-Text   |   Download PDF [1820 KB, uploaded 13 June 2017]   |  

Abstract

Cartilage defects represent a serious problem due to the poor regenerative properties of this tissue. Regarding the nose, nasal valve collapse is associated with nasal blockage and persistent airway obstruction associated with a significant drop in the quality of life for patients. In addition to surgical techniques, several cell-based tissue-engineering strategies are studied to improve cartilage support in the nasal wall, that is, to ameliorate wall insufficiency. Nevertheless, there are no congruent data available on the benefit for patients during the follow-up time. In this manuscript, we propose an innovative approach in the treatment of cartilage defects in the nose (nasal valve collapse) based on autologous micro-grafts obtained by mechanical disaggregation of a small portion of cartilage tissue (Rigenera® protocol). In particular, we first analyzed in vitro murine and human cartilage micro-grafts; secondly, we analyzed the clinical results of a patient with pinched nose deformity treated with autologous micro-grafts of chondrocytes obtained by Rigenera® protocol. The use of autologous micro-graft produced promising results in surgery treatment of cartilage injuries and could be safely and easily administrated to patients with cartilage tissue defects. View Full-Text
Keywords: Rigenera® protocol; autologous micro-grafts; chondrocytes; tissue engineering approaches; nasal valve collapse Rigenera® protocol; autologous micro-grafts; chondrocytes; tissue engineering approaches; nasal valve collapse
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ceccarelli, G.; Gentile, P.; Marcarelli, M.; Balli, M.; Ronzoni, F.L.; Benedetti, L.; Cusella De Angelis, M.G. In Vitro and In Vivo Studies of Alar-Nasal Cartilage Using Autologous Micro-Grafts: The Use of the Rigenera® Protocol in the Treatment of an Osteochondral Lesion of the Nose. Pharmaceuticals 2017, 10, 53.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top